RADx Tech For Accessible Tests - CIMIT MAIN

CIMIT is a network of world-class academic and medical institutions partnering with industry and government. Our mission is to foster collaboration among clinicians, technologists, and entrepreneurs to accelerate innovation and catalyze the discovery, development, and implementation of innovative healthcare technologies.

Learn More >

Initiatives and Funding Opportunities

null RADx Tech For Accessible Tests

RADx Tech COVID-19 Funding Opportunity: COVID-19 Home Tests Accessible to People with Disabilities

The RADx Coordination Center at CIMIT, on behalf of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH), is soliciting proposals for accessible over-the-counter (OTC) testing technologies for COVID-19 under its Rapid Acceleration of Diagnostics (RADx) fast-track program.

Under this RADx Tech solicitation, NIBIB is seeking to accelerate the development of OTC COVID-19 diagnostic technologies that can be used independently by people with disabilities. To specifically meet the needs of populations with disabilities (e.g., blindness, low vision, fine motor skill difficulties, and aging-related disabilities) innovations should incorporate universal design features and provide significantly improved accessibility and ease-of-use compared to existing commercial platforms. Proposals should utilize universal design principles such that solutions will improve the usability of OTC tests for all users. Clinical and technical performance must be at least as good as current, best-in-class OTC technologies. Test platforms should return results quickly, demonstrate potential for integration with digital health reporting standards, and be capable of achieving regulatory clearance during both pandemic and non-pandemic periods.

Learn more or apply by October 14>

Latest News

3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19

The goal is a new, highly accurate, mass-produced low-cost diagnostic device that delivers results in minutes. Read MoreAbout3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19 »

Webinar: RADx Tech - Two Years in Retrospect and the Future in Perspective

Dr. Bruce Tromberg reflects on the RADx Tech experiment and experiences. He will also share his thoughts about future challenges and opportunities. Read MoreAboutWebinar: RADx Tech - Two Years in Retrospect and the Future in Perspective »

Webinar: Beyond Epitope Mapping

Using Deep Mutational Scanning to Generate a Complete Map of SARS-CoV-2 Diagnostic Antibody Escape Mutations Read MoreAboutWebinar: Beyond Epitope Mapping »